293 related articles for article (PubMed ID: 7994190)
21. Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions.
Body JJ
Breast; 2003 Aug; 12 Suppl 2():S37-44. PubMed ID: 14659142
[TBL] [Abstract][Full Text] [Related]
22. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
Hussein O; Tiedemann K; Komarova SV
Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
[TBL] [Abstract][Full Text] [Related]
25. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
Piper K; Boyde A; Jones SJ
Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.
Hughes DE; MacDonald BR; Russell RG; Gowen M
J Clin Invest; 1989 Jun; 83(6):1930-5. PubMed ID: 2524504
[TBL] [Abstract][Full Text] [Related]
28. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
Meng YH; Peng Y; Liu D; Chen Y; Wang H; Liang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):107-11. PubMed ID: 21426781
[TBL] [Abstract][Full Text] [Related]
29. New insights into the molecular mechanisms of action of bisphosphonates.
Rogers MJ
Curr Pharm Des; 2003; 9(32):2643-58. PubMed ID: 14529538
[TBL] [Abstract][Full Text] [Related]
30. Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo.
van der Pluijm G; Binderup L; Bramm E; van der Wee-Pals L; De Groot H; Binderup E; Löwik C; Papapoulos S
J Bone Miner Res; 1992 Aug; 7(8):981-6. PubMed ID: 1442212
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
32. A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms.
Nishikawa M; Yamamoto M; Murakami T; Akatsu T; Kugai N; Nagata N
J Bone Miner Res; 1998 Jun; 13(6):986-95. PubMed ID: 9626630
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular mechanisms of action of bisphosphonates.
Rogers MJ; Gordon S; Benford HL; Coxon FP; Luckman SP; Monkkonen J; Frith JC
Cancer; 2000 Jun; 88(12 Suppl):2961-78. PubMed ID: 10898340
[TBL] [Abstract][Full Text] [Related]
34. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
Lerner UH; Larsson A
Bone; 1987; 8(3):179-89. PubMed ID: 2955802
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
Carano A; Teitelbaum SL; Konsek JD; Schlesinger PH; Blair HC
J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
[TBL] [Abstract][Full Text] [Related]
36. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
Sato M; Grasser W
J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
[TBL] [Abstract][Full Text] [Related]
37. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
van beek E; Löwik C; van der Pluijm G; Papapoulos S
J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
[TBL] [Abstract][Full Text] [Related]
38. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
Moran EL; Fornasier TL; Bogoch TR
J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
[TBL] [Abstract][Full Text] [Related]
39. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.
Benford HL; McGowan NW; Helfrich MH; Nuttall ME; Rogers MJ
Bone; 2001 May; 28(5):465-73. PubMed ID: 11344045
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.
Nishikawa M; Akatsu T; Katayama Y; Yasutomo Y; Kado S; Kugal N; Yamamoto M; Nagata N
Bone; 1996 Jan; 18(1):9-14. PubMed ID: 8717530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
